ES2059814T3 - Agentes de contraste por ultrasonidos a base de burbujas de gas y microparticulas que contienen acidos grasos. - Google Patents

Agentes de contraste por ultrasonidos a base de burbujas de gas y microparticulas que contienen acidos grasos.

Info

Publication number
ES2059814T3
ES2059814T3 ES89730095T ES89730095T ES2059814T3 ES 2059814 T3 ES2059814 T3 ES 2059814T3 ES 89730095 T ES89730095 T ES 89730095T ES 89730095 T ES89730095 T ES 89730095T ES 2059814 T3 ES2059814 T3 ES 2059814T3
Authority
ES
Spain
Prior art keywords
gas bubbles
ultrasonics
fatty acids
microparticles containing
contrast agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89730095T
Other languages
English (en)
Inventor
Lothar Prof Lange
Jurgen Hilmann
Thomas Dr Fritzsch
Joachim Dr Siegert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Application granted granted Critical
Publication of ES2059814T3 publication Critical patent/ES2059814T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasonic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasonic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3925—Markers, e.g. radio-opaque or breast lesions markers ultrasonic

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Acoustics & Sound (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Fats And Perfumes (AREA)
  • Junction Field-Effect Transistors (AREA)
  • Air Conditioning Control Device (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Gyroscopes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

EL INVENTO DESCRIBE UN MEDIO DE CONTRASTE PARA LA DIAGNOSIS DEL ULTRASONIDO A BASE DE BURBUJAS DE GAS Y MICROPARTICULAS Y SE CARACTERIZA PORQUE COMO MICROPARTICULAS CONTIENEN UNA MEZCLA DE ACIDO GRASO DE C10 A 20 CON UNA SUSTANCIA SOLIDA NO ACTIVADORA DE SUPERFICIES LIMITES SUSPENDIDA EN UN SOPORTE FLUIDO. SE CONFIGURA EN EL SOPORTE DE CONTRASTE SEGUN APLICACION INTRAVENOSA LA EMISION DE CONTRASTE DE LA PARTE DERECHA E IZQUIERDA DEL CORAZON, EL MIOCARDIO Y OTRROS ORGANOS COMO HIGADO, BAZO O RIÑON.
ES89730095T 1988-10-07 1989-04-06 Agentes de contraste por ultrasonidos a base de burbujas de gas y microparticulas que contienen acidos grasos. Expired - Lifetime ES2059814T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3834705A DE3834705A1 (de) 1988-10-07 1988-10-07 Ultraschallkontrastmittel aus gasblaeschen und fettsaeure enthaltenden mikropartikeln

Publications (1)

Publication Number Publication Date
ES2059814T3 true ES2059814T3 (es) 1994-11-16

Family

ID=6364930

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89730095T Expired - Lifetime ES2059814T3 (es) 1988-10-07 1989-04-06 Agentes de contraste por ultrasonidos a base de burbujas de gas y microparticulas que contienen acidos grasos.

Country Status (19)

Country Link
EP (1) EP0365467B1 (es)
JP (1) JPH0737394B2 (es)
KR (1) KR970001433B1 (es)
CN (1) CN1027575C (es)
AT (1) ATE93145T1 (es)
AU (1) AU627456B2 (es)
CA (1) CA1338507C (es)
DE (2) DE3834705A1 (es)
DK (1) DK99789A (es)
ES (1) ES2059814T3 (es)
FI (1) FI100170B (es)
IE (1) IE65243B1 (es)
IL (1) IL90028A (es)
LU (1) LU90004I2 (es)
NL (1) NL970009I2 (es)
NO (2) NO178139C (es)
NZ (1) NZ228781A (es)
PT (1) PT91523B (es)
ZA (1) ZA892885B (es)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993000930A1 (en) * 1991-07-05 1993-01-21 Holmes, Michael, John Improvements in or relating to contrast agents
US6723303B1 (en) 1991-09-17 2004-04-20 Amersham Health, As Ultrasound contrast agents including protein stabilized microspheres of perfluoropropane, perfluorobutane or perfluoropentane
MX9205298A (es) * 1991-09-17 1993-05-01 Steven Carl Quay Medios gaseosos de contraste de ultrasonido y metodo para seleccionar gases para usarse como medios de contraste de ultrasonido
CA2119129C (en) * 1991-09-17 1999-11-09 Steven C. Quay Gaseous ultrasound contrast media and method for selecting gases for use as ultrasound contrast media
US5409688A (en) * 1991-09-17 1995-04-25 Sonus Pharmaceuticals, Inc. Gaseous ultrasound contrast media
US5196183A (en) * 1991-12-04 1993-03-23 Sterling Winthrop Inc. Contrast agents for ultrasound imaging
GB9200387D0 (en) * 1992-01-09 1992-02-26 Nycomed As Improvements in or relating to contrast agents
GB9200388D0 (en) * 1992-01-09 1992-02-26 Nycomed As Improvements in or relating to contrast agents
US5558855A (en) * 1993-01-25 1996-09-24 Sonus Pharmaceuticals Phase shift colloids as ultrasound contrast agents
NZ262237A (en) * 1993-01-25 1997-06-24 Sonus Pharma Inc Ultrasound contrast agents comprising phase shift colloids having a boiling point below the body temperature of the animal it is used in
IL108416A (en) 1993-01-25 1998-10-30 Sonus Pharma Inc Phase shift colloids as ultrasound contrast agents
RU2125466C1 (ru) * 1993-11-30 1999-01-27 Шеринг Аг Ультразвуковая контрастная среда, содержащая газонаполненные микрочастицы, способ получения микрочастиц (варианты), газонаполненные микрочастицы
GB9402867D0 (en) * 1994-02-15 1994-04-06 Nycomed Imaging As Improvements in or relating to contrast agents
DE4406474A1 (de) * 1994-02-23 1995-08-24 Schering Ag Gas enthaltende Mikropartikel, diese enthaltende Mittel, deren Verwendung in der Ultraschalldiagnostik, sowie Verfahren zur Herstellung der Partikel und Mittel
EP0699445A3 (en) * 1994-08-04 1996-04-17 Gakko Houjin Toin Gakuen Process for the preparation of an ultrasonic microbubble contrast agent with a surfactant
DE19602930A1 (de) * 1996-01-18 1997-07-24 Schering Ag Poröse Matrices aus niedermolekularen Substanzen zur Genierung stabiler Gasblasensuspensionen, deren Verwendung als Ultraschallkontrastmittel sowie Verfahren zu deren Herstellung
GB9808582D0 (en) * 1998-04-22 1998-06-24 Nycomed Imaging As Improvements in or relating to contrast agents
EP1140211A1 (en) 1998-10-12 2001-10-10 Mallinckrodt Inc. Novel ultrasound contrast agents
DE19950311A1 (de) * 1999-10-13 2001-04-19 Schering Ag Die Verwendung von Trockenstopfen zur Erhöhung der Lagerstabilität von Ultraschallkontrastmitteln
DE19952738A1 (de) * 1999-10-27 2001-05-23 Schering Ag Verbesserte Suspensionen von Ultraschallkontrastmitteln
JP5078212B2 (ja) 2000-06-02 2012-11-21 ブラッコ・スイス・ソシエテ・アノニム 内皮細胞を標的とするための化合物、それを含む組成物およびその使用方法
ATE376803T1 (de) 2001-04-06 2007-11-15 Bracco Research Sa Vorrichtung zur messung lokaler physikalischer parameter in einem flüssigkeitsgefüllten hohlraum
SI2301587T1 (sl) 2002-03-01 2014-11-28 Dyax Corp. KDR in VEGF/KDR vezavni peptidi in njihova uporaba pri diagnozi
US8623822B2 (en) 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
WO2004065621A1 (en) 2002-03-01 2004-08-05 Dyax Corp. Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
US7211240B2 (en) 2002-03-01 2007-05-01 Bracco International B.V. Multivalent constructs for therapeutic and diagnostic applications
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
US7794693B2 (en) 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
US7131997B2 (en) 2002-03-29 2006-11-07 Scimed Life Systems, Inc. Tissue treatment
US7094369B2 (en) 2002-03-29 2006-08-22 Scimed Life Systems, Inc. Processes for manufacturing polymeric microspheres
US7462366B2 (en) 2002-03-29 2008-12-09 Boston Scientific Scimed, Inc. Drug delivery particle
US7053134B2 (en) 2002-04-04 2006-05-30 Scimed Life Systems, Inc. Forming a chemically cross-linked particle of a desired shape and diameter
US7449236B2 (en) 2002-08-09 2008-11-11 Boston Scientific Scimed, Inc. Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
US7842377B2 (en) 2003-08-08 2010-11-30 Boston Scientific Scimed, Inc. Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
US8012454B2 (en) 2002-08-30 2011-09-06 Boston Scientific Scimed, Inc. Embolization
US7588825B2 (en) 2002-10-23 2009-09-15 Boston Scientific Scimed, Inc. Embolic compositions
US7883490B2 (en) 2002-10-23 2011-02-08 Boston Scientific Scimed, Inc. Mixing and delivery of therapeutic compositions
ES2557286T3 (es) 2003-03-03 2016-01-25 Dyax Corp. Usos de péptidos que se unen específicamente al receptor del HGF (cMet)
US7976823B2 (en) 2003-08-29 2011-07-12 Boston Scientific Scimed, Inc. Ferromagnetic particles and methods
US7901770B2 (en) 2003-11-04 2011-03-08 Boston Scientific Scimed, Inc. Embolic compositions
KR101001547B1 (ko) 2004-01-28 2010-12-17 삼성에스디아이 주식회사 섬유상 태양 전지 및 이의 제조 방법
US7736671B2 (en) 2004-03-02 2010-06-15 Boston Scientific Scimed, Inc. Embolization
US8173176B2 (en) 2004-03-30 2012-05-08 Boston Scientific Scimed, Inc. Embolization
US7311861B2 (en) 2004-06-01 2007-12-25 Boston Scientific Scimed, Inc. Embolization
US8012457B2 (en) 2004-06-04 2011-09-06 Acusphere, Inc. Ultrasound contrast agent dosage formulation
US8425550B2 (en) 2004-12-01 2013-04-23 Boston Scientific Scimed, Inc. Embolic coils
US7727555B2 (en) 2005-03-02 2010-06-01 Boston Scientific Scimed, Inc. Particles
US7858183B2 (en) 2005-03-02 2010-12-28 Boston Scientific Scimed, Inc. Particles
US7963287B2 (en) 2005-04-28 2011-06-21 Boston Scientific Scimed, Inc. Tissue-treatment methods
US9463426B2 (en) 2005-06-24 2016-10-11 Boston Scientific Scimed, Inc. Methods and systems for coating particles
US8007509B2 (en) 2005-10-12 2011-08-30 Boston Scientific Scimed, Inc. Coil assemblies, components and methods
US8101197B2 (en) 2005-12-19 2012-01-24 Stryker Corporation Forming coils
US8152839B2 (en) 2005-12-19 2012-04-10 Boston Scientific Scimed, Inc. Embolic coils
US7947368B2 (en) 2005-12-21 2011-05-24 Boston Scientific Scimed, Inc. Block copolymer particles
US7501179B2 (en) 2005-12-21 2009-03-10 Boston Scientific Scimed, Inc. Block copolymer particles
US8414927B2 (en) 2006-11-03 2013-04-09 Boston Scientific Scimed, Inc. Cross-linked polymer particles
JP5196896B2 (ja) * 2007-07-13 2013-05-15 花王株式会社 微細気泡前駆体の製造方法
WO2021141595A1 (en) * 2020-01-10 2021-07-15 Advanced Microbubbles Laboratories Llc Preparation and preservation of collagen microbubbles

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3640271A (en) 1969-06-30 1972-02-08 Ibm Blood flow pressure measurement technique employing injected bubbled and ultrasonic frequency scanning
US4276885A (en) 1979-05-04 1981-07-07 Rasor Associates, Inc Ultrasonic image enhancement
US4265251A (en) 1979-06-28 1981-05-05 Rasor Associates, Inc. Method of determining pressure within liquid containing vessel
EP0052575B1 (en) 1980-11-17 1986-01-08 Schering Aktiengesellschaft Composition generating microbubbles
DE3141641A1 (de) 1981-10-16 1983-04-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen Ultraschall-kontrastmittel und dessen herstellung
JPS5920532A (ja) * 1982-07-23 1984-02-02 Nippon Denso Co Ltd 車載内燃機関の燃料調量制御方法
DE3313946A1 (de) * 1983-04-15 1984-10-18 Schering AG, 1000 Berlin und 4709 Bergkamen Mikropartikel und gasblaeschen enthaltende ultraschall-kontrastmittel
DE3313947A1 (de) * 1983-04-15 1984-10-18 Schering AG, 1000 Berlin und 4709 Bergkamen Mikropartikel und gasblaeschen enthaltende ultraschall-kontrastmittel
DE3637926C1 (de) * 1986-11-05 1987-11-26 Schering Ag Ultraschall-Manometrieverfahren in einer Fluessigkeit mittels Mikroblaeschen

Also Published As

Publication number Publication date
AU627456B2 (en) 1992-08-27
FI890749A0 (fi) 1989-02-16
NO178139B (no) 1995-10-23
FI890749L (fi) 1990-04-08
NL970009I2 (nl) 1997-08-01
IE65243B1 (en) 1995-10-04
JPH0737394B2 (ja) 1995-04-26
NO890609L (no) 1990-04-09
NZ228781A (en) 1992-03-26
EP0365467B1 (de) 1993-08-18
CN1027575C (zh) 1995-02-08
CN1044225A (zh) 1990-08-01
IL90028A0 (en) 1989-12-15
KR970001433B1 (ko) 1997-02-06
IE891149L (en) 1990-04-07
PT91523A (pt) 1990-04-30
JPH02145528A (ja) 1990-06-05
NL970009I1 (nl) 1997-05-01
DE3834705A1 (de) 1990-04-12
NO890609D0 (no) 1989-02-13
FI100170B (fi) 1997-10-15
DK99789A (da) 1990-04-08
AU3390089A (en) 1990-04-12
DE58905318D1 (de) 1993-09-23
NO1998014I1 (no) 1998-05-05
DK99789D0 (da) 1989-03-01
CA1338507C (en) 1996-08-06
EP0365467A3 (en) 1990-06-06
EP0365467A2 (de) 1990-04-25
KR900005939A (ko) 1990-05-07
LU90004I2 (fr) 1997-03-04
NO178139C (no) 1996-01-31
ATE93145T1 (de) 1993-09-15
PT91523B (pt) 1995-05-31
IL90028A (en) 1993-01-31
ZA892885B (en) 1990-12-28

Similar Documents

Publication Publication Date Title
NL970009I2 (nl) Ultrageluidscontrastmiddel uit gasbelletjes en vethzuurhoudende microdeeltjes.
BR9206639A (pt) Processo para a preparação de uma composição aquosa desinfetante composição desinfetante sistema de duas embalagens processo composição ou sistema de duas embalagens e usa da composição
ES2184138T3 (es) Composicion y procedimiento para tratar plantas con productos quimicos exogenos.
MX9102814A (es) Forma de administracion para agentes ecocontrastantes en microburbujas.
GB9423419D0 (en) Preparation of hollow microcapsules
BR9911993A (pt) Método de desinfecção, volume desinfetado, composição desinfetante, névoa desinfetante e artigo desinfetado e aparelhagem para desinfecção
ES2192553T3 (es) Jaula de fusion de configuracion conica.
DK0619743T3 (da) Stabile mikroboblesuspensioner som forstærkere til ultralyds-ekkografi
NO970748L (no) Forbindelser, farmasöytisk blanding og diagnostisk anordning som omfatter de samme, og deres anvendelse
DE3674570D1 (de) N,n-dimethyl-1-(1-(4-chlorophenyl)-cyclobutyl)-3-methylbutylamin-hydrochlorid, monohydrat und pharmazeutische zusammensetzungen, welche diese enthalten.
ES2018729A6 (es) Un metodo para preparar una variante de activador de plasmogeno de tejido.
AR002932A1 (es) Solucion acuosa de interferon
DE69816297D1 (de) Verfahren und zusammensetzungen des gewebefaktors zur koagulation und behandlung von tumoren
AR032883A1 (es) Metodo de tratamiento de flavivirus y pestivirus
ZA827577B (en) Liquid mixture for taking up and stabilising gas bubbles,and its manufacture and use as a contrast medium for ultrasonic diagnosis
DE69735354D1 (de) Verbesserungen an oder in verbindung mit diagnotischen/therapeutischen verbindungen
CY1112580T1 (el) Συνθεσεις και μεθοδοι για βελτιωμενη απελευθερωση υδροφοβων θεραπευτικων παραγοντων
BR9708553A (pt) Processo para limpeza de um substrato e uso de umsistema ativador de oxigenio molecular
NL970008I2 (nl) Derivaat van een weefselplasminogeenactivator.
EA200401565A1 (ru) Способ получения кардиолипина или аналога кардиолипина (варианты), способ получения липосомы и композиция кардиолипина для лечения заболеваний (варианты)
ES2081805T3 (es) Acidos 5r,6s-6-(1r-hidroxietil)-2-(cis-1-oxo-3-tiolaniltio)-2-penem-3-carboxilicos diastereoisomeros.
DK657689D0 (da) Middel med biologisk virkning paa tarmslimhinden
DE59507521D1 (de) Milde, wässrige, tensidische Zubereitungen für kosmetische Zwecke und Reinigungsmittel
MX9302924A (es) Agente para tratamiento de cataratas y metodo para su preparacion.
ES2031462T3 (es) Procedimiento para producir 1-b-d-arabinofuranosilcitosina-5'-estearilfosfato monosodico y monohidrato de la misma, y compuesto farmaceutico que contiene esta ultima.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 365467

Country of ref document: ES

SPCF Request for supplementary protection certificate filed

Free format text: LEVOVIST

Spc suppl protection certif: C9800006

Filing date: 19980129

SPCG Supplementary protection certificate granted

Free format text: LEVOVIST

Spc suppl protection certif: C9800006

Filing date: 19980129

Expiry date: 20100621